Euthymics Bioscience
  • Home
  • Our Family of Companies
    • Euthymics Bioscience: Major Depressive Disorder and Amitifadine
    • Neurovance: ADHD and EB-1020
  • Our Technology
  • About
    • About Euthymics
    • Management
    • Board of Directors
  • Contact
  • News

News

  • News
    • Corporate Fact Sheet
    • In The News
    • Press Releases
    • Publications
Home    >    In The News

In The News

July 10, 2012 - TRIADE clinical investigator Dr. Ashokkumar C. Patel discusses the TRIADE trial on Scranton, PA’s ABC affiliate WNEP


July 5, 2012 - Clinical investigator Dr. Kashinath Yadalam discusses amitifadine and the TRIADE trial on Lake Charles, LA’s 7News NBC


June 20, 2012 - TRIADE clinical investigator Dr. Greg Mattingly discusses depression and amitifadine on St. Louis’ Fox 2


February 22, 2012 - Clinical investigator Dr. Donald Garcia discusses the TRIADE study on Austin’s NBC affiliate KXAN


February 15, 2012 - Clinical investigator Dr. Ronald Fuchs discusses TRIADE and amitifadine on Philadelphia’s 6 ABC


February 7, 2012 - TRIADE clinical investigator Dr. Riaz Baber discusses the trial and amitifadine in the Naperville Sun


January 15, 2012 - Dr. Michael Downing, TRIADE clinical investigator, discusses depression and amitifadine on Dallas’ DFW Closeup


December 13, 2011 - TRIADE investigator Dr. Eugene DuBoff discusses depression and Euthymics’ amitifadine in The Denver Post


December 5, 2011 - Euthymics Featured in BioCentury Emerging Company Profile


November 23, 2011 - TRIADE clinical trial investigator Dr. Kashinath Yadalam discusses TRIADE and Euthymics’ amitifadine on Lake Charles, LA’s KPLC


Privacy Policy  |  Terms of Use Copyright ©2013 Euthymics Bioscience. All Rights Reserved.